EarningsQ3 2022 Earnings Report

Novartis (NVSN) Q3 2022 Earnings Report

0 Followers

MX:NVSN Q3 2022 EPS Results

Actual EPS$27.58

Consensus EPS$27.07

Beat/MissBeat by +$0.52

One Year Ago EPS$29.85

Actual Revenue$230.04B

Expected Revenue$237.25B

Beat/MissMissed by -$7.21B

YoY Revenue Growth-4.13%

QuarterQ3 2022

Date10/25/2022

TimeBefore Open

Conference CallTuesday, October 25, 2022

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

MX:NVSN Q3 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	41.87 / -	41.432	―
Jul 21, 2026	2026 (Q2)	40.00 / 44.38	44.562	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	38.63 / 36.64	41.984	-12.72% (-5.34)
Feb 04, 2026	2025 (Q4)	36.52 / 37.38	36.46	2.53% (+0.92)
Oct 28, 2025	2025 (Q3)	41.86 / 41.43	37.933	9.22% (+3.50)
Jul 17, 2025	2025 (Q2)	43.29 / 44.56	36.276	22.84% (+8.29)
Apr 29, 2025	2025 (Q1)	38.93 / 41.98	33.146	26.67% (+8.84)
Jan 31, 2025	2024 (Q4)	33.24 / 36.46	28.174	29.41% (+8.29)
Oct 29, 2024	2024 (Q3)	35.69 / 37.93	32.041	18.39% (+5.89)
Jul 18, 2024	2024 (Q2)	34.07 / 36.28	31.93	13.61% (+4.35)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed